Úsek pro vědu a výzkum

Professional Publications

Author
Title
Year of publication

Publications (3663)

[561]

Racil, Z.; Razga, F.; Klamova, H.; Voglova, J.; Belohlavkova, P.; Malaskova, L.; Potesil, D.; Muzik, J.; Zackova, D.; Polakova, K.M.; Zdrahal, Z.; Malakova, J.; Suttnar, J.; Dyr, J.; Mayer, J.

Erratum: No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia

[year of publication 2015, impact factor 3.084 ]

[562]

Cremers, E.M.; van Biezen, A.; de Wreede, L.; Scholten, M.; Vitek, A.; Finke, J.; Platzbecker, U.; Beelen, D.; Schwerdtfeger, R.; Volin, L.; Harhalakis, N.; Blijlevens, N.; Nagler, A.; Kröger, N.; de Witte, T.

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

[year of publication 2016, impact factor 3.083 ]

[563]

Němečková, Š.; Ludvíková, V.; Marešová, L.; Kryštofová, J.; Hainz, P.; Kutinová, L.

Induction of varicella-zoster virus-neutralizing antibodies in mice by coinfection with recombinant vaccinia viruses expressing the gH or gL gene

[year of publication 2006, impact factor 3.080]

[564]

Rector, A.; Tachezy, R.; Van Doorslaer, K.; MacNamara, T.; Burk, R.D.; Sundberg, J.P.; Van Ranst, M.:

Isolation and cloning of a papillomavirus from a North American porcupine by using multiply primed rolling-circle amplification : the Erethizon dorsatum papillomavirus type 1.

[year of publication 2006, impact factor 3.080]

[565]

Hamsikova, E.; Ludvikova, V.; Stasikova, J.; Tachezy, R.

Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic

[year of publication 2012, impact factor 3.078 ]

[566]

Kutinová, L.; Ludvíková, V.; Marešová, L.; Němečková, Š.; Brouček, J.; Hainz, P.; Vonka, V.

Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens : antibody-response inhibition induced by immunization with a mixture of recombinants differing in virulence

[year of publication 2006, impact factor 3.061]

[567]

Sutherland, D.R.; Richards, S.J.; Ortiz, F.; Nayyar, R.; Benko, M.; Marinov, I.; Illingworth, A.

CD71 improves delineation of PNH type III, PNH type II, and normal immature RBCS in patients with paroxysmal nocturnal hemoglobinuria

[year of publication 2019, impact factor 3.058 ]

[568]

Lorkova, L.; Scigelova, M.; Arrey, T.N.; Vit, O.; Pospisilova, J.; Klanova, M.; Alam, M. ; Vockova, P.; Maswabi, B.; Klener, P. Jr.; Petrak, J.

Detailed functional and proteomic characterization of fludarabine resistance in mantle cell lymphoma cells

[year of publication 2015, impact factor 3.057 ]

[569]

Kuželová, K.; Brodská, B.; Fuchs, O.; Dobrovolná, M.; Soukup, P.; Cetkovský, P.

Altered HLA class I profile associated with type A/D nucleophosmin mutation points to possible anti-nucleophosmin immune response in acute myeloid leukemia

[year of publication 2015, impact factor 3.057 ]

[570]

Mikyšková, R.; Indrová, M.; Šímová, J.; Jandlová, T.; Bieblová, J.; Jinoch, P.; Bubeník, J.; Vonka, V.

Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours : cytokine and gene therapy with IL-2 and GM-CSF

[year of publication 2006, impact factor 3.056]

[571]

Mackova, J.; Kutinova, L.; Hainz, P.; Krystofova, J.; Sroller, V.; Otahal, P.; Gabriel, P.; Nemeckova, S.

Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12

[year of publication 2006, impact factor 3.056]

[572]

Sabol, I.; Smahelova, J.; Klozar, J.; Mravak-Stipetic, M.; Gheit, T.; Tommasino, M.; Grce, M.; Tachezy, R.

Beta-HPV types in patients with head and neck pathology and in healthy subjects

[year of publication 2016, impact factor 3.051 ]

[573]

aut. Brynda, E.

Characterization of flexibility of ultrathin protein films by optical sensing

[year of publication 2006, impact factor 3.045]

[574]

Jarolim, P.

The phage display technique and transfusion medicine

[year of publication 2006, impact factor 3.045]

[575]

Suchan, P.; Vyoral, D.; Petrák, J.; Šuťák, R.; Rasoloson, D.; Nohýnková, E.; Doležal, P.; Tachezy, J.

Incorporation of iron into Tritrichomonas foetus cell compartments reveals ferredoxin as a major iron-binding protein in hydrogenosomes

[year of publication 2006, impact factor 3.044]

[576]

Hütter, G.; Bodor, J.; Ledger, S.; Boyd, M.; Millington, M.; Tsie, M.; Symonds, G.

CCR5 targeted cell therapy for hiv and prevention of viral escape

[year of publication 2015, impact factor 3.042 ]

[577]

McNees, A.L.; Vilchez, R.A.; Heard, T.C.; Sroller, V.; Wong, C.; Herron, A.J.; Hamilton, M.J.; Davis, W.C.; Butel, J.S.

SV40 lymphomagenesis in Syrian golden hamsters

[year of publication 2009, impact factor 3.042]

[578]

Patel, N.C.; Halvorson, S.J.; Sroller, V.; Arrington, A.S.; Wong, C.; Smith, E.O.; Vilchez, R.A.; Butel, J.S.

Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters

[year of publication 2009, impact factor 3.042]

[579]

Písačka, M.; Marinov, I.; Králová, M.; Králová, J.; Kořánová, M.; Bohoněk, M.; Sood, C.; Ochoa-Garay, G.

FY*A silencing by the GATA-motif variant FY*A(-69C) in a Caucasian family

[year of publication 2015, impact factor 3.042 ]

[580]

Volejnikova, J.; Vojta, P.; Urbankova, H.; Mojzikova, R.; Horvathova, M.; Hochova, I.; Cermak, J.; et al.

Czech and Slovak Diamond-Blackfan Anemia (DBA) Registry update: clinical data and novel causative genetic lesions

[year of publication 2020, impact factor 3.039 ]